ISLH Online Education

Inventory of Guidelines

ISLH is committed to ensuring an up to date inventory of guidelines that support the Hematology Laboratory community. You may view our inventory of guidelines by selecting a category/topic below. Please note that the search/sort options will only include guidelines for the currently selected category/topic.

Pre-Analytical

Guideline Title	Organization	Year	Action
ISO 15189:2022 Medical Laboratories – Requirements for quality and competence	ISO	2022	View
International normalized ratio and activated partial thromboplastin time testing		2022	View
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing	ICSH	2021	View
Recommendations for estimating measurement uncertainty in medical laboratories (ISO 15189 and ISO 20914)	SIPMeL	2021	View
Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies	ISTH/SSC	2021	View
Optimal Testing: AACC's Guide to Lab Test Utilization	AACC	2020	View
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis	BSH	2020	View
Strategies for eliciting and synthesizing evidence for guidelines in rare diseases	BMC	2019	View
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum	Anticoagulation Forum	2019	View
Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.	Croatian Society of Medical Biochemistry and Laboratory Medicine	2019	View
Joint EFLM-COLABIOCLI Recommendation for venous blood sampling	EFLM-COLABIOCLI	2018	View

Hematopathology

Guideline Title	Organization	Year	Action
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer	CCMG and Canadian Association of Pathologists	2022	View
Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies	CAP	2021	View

Coagulation

Guideline Title	Organization	Year	Action
Assays to quantify fibrinolysis: strengths and limitations. Communication from the ISTH SSC Subcommittee on Fibrinolysis	ISTH SSC	2023	View
Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis	ISTH SSC	2022	View
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee	ISTH SSC	2022	View
Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies	ISTH SSC	2022	View
Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline	United Kingdom Haemophilia Centre Doctors’ Organisation	2022	View
Heparin Resistance — Clinical Perspectives and Management Strategies		2021	View
Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH	ISTH SSC	2021	View
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulant	ICSH	2021	View
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis	ISTH SSC	2020	View
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis	ISTH SSC	2020	View
Update of the guidelines for lupus anticoagulant detection and interpretation	ISTH SSC	2020	View
Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH	ISTH SSC	2020	View
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH	ISTH SSC	2019	View
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants	ICSH	2018	View
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH	ISTH SSC	2018	View
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative	NIH	2017	View
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations	NIH	2017	View
Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL	Blood Transfusion	2017	View
Internal quality control practices in coagulation laboratories: recommendations based on a patterns-of-practice survey	IQMH	2015	View
Diagnosis of inherited platelet function disorders: Guidance from the SSC of the ISTH	ISTH	2015	View
Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH	ISTH	2014	View
Validation of hemostasis and coagulation assays: recommendations and guidelines	Independent authors (STH)	2014	View
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology	UKHCDO / BCSH	2014	View

Hemoglobinopathies and Red Cell Disorders

Guideline Title	Organization	Year	Action
Evidence to Improve Care: Sickle Cell Disease – Care for People of All Ages	Health Quality Ontario	2023	View
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support	ASH	2020	View
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain	ASH	2020	View
ICSH recommendations for assessing automated high-performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2	ICSH	2015	View
ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders	ICSH	2015	View
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes	ICSH	2011	View
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes	ICSH	2011	View

Cellular Analysis

Guideline Title	Organization	Year	Action
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.	WHO	2016	View
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology	CAP	2016	View
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features	ICSH	2015	View
ICSH guidelines for the standardization of bone marrow immunohistochemistry	ICSH	2015	View
ICSH guidelines for the evaluation of blood cell analyzers including those used for differential leucocyte and reticulocyte counting	ICSH	2014	View
ICSH guidelines for the verification and performance of automated cell counters for body fluids	ICSH	2014	View

Flow Cytometry

Guideline Title	Organization	Year	Action
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology	ISTH SSC	2021	View
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders	ICCS/ESCCA	2018	View
Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group	PBC	2016	View
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10	ESCCA	2011	View

COVID

Guideline Title	Organization	Year	Action
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH	ISTH SSC	2022	View
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH	ISTH SSC	2022	View
Antithrombotic agents in patients with COVID-19	CMAJ	2022	View
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S		2022	View
COVID-Inflicted Coagulopathy: Expert Consensus on Management with Novel Oral Anticoagulants in India		2021	View
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19	Ontario Science Table	2022	View
Alert to Health Care Professionals about a potential drug-drug interaction between Paxlovid and anticoagulants	Thrombosis Canada	2022	View
WHO recommends two new drugs to treat COVID-19	WHO	2022	View
The COVID-19 Treatment Guidelines Panel's Statement on Anticoagulation in Hospitalized Patients With COVID-19	NIH	2022	View
Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario	Ontario Science Table	2021	View
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources		2021	View
VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme	UK Expert Haematology Panel	2021	View
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19	ADD	2021	View
Evidence-Based Use of Therapeutics for Ambulatory Patients with COVID-19	Ontario Science Table	2021	View
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19	Ontario Science Table	2021	View
COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT)	NICE	2021	View
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome(TTS) following vaccination to prevent coronavirus disease (COVID-19)	WHO	2021	View
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets	EMA	2021	View
The ISTH Releases Interim Guidance on Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)	ISTH	2021	View
Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology	ISTH SSC	2021	View
Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology	ISTH SSC	2021	View
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting	COVID-19 Advisory for Ontario	2021	View
Recognizing, managing and reporting vaccineinduced immune thrombotic thrombocytopenia		2021	View
Intensive Care guidance for the management of vaccine induced immune-thrombocytopenia and thrombosis (VITT)	UK Intensive Care Society and NACCS	2021	View
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing	Infectious Diseases Society of America	2021	View
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19	ASH	2021	View
The ADAMTS13-von Willebrand factor axis in COVID-19 patients		2021	View
A living WHO guideline on drugs to prevent covid-19	WHO	2021	View
Thrombosis Canada Statement on Astrazeneca COVID-19 Vaccine and Thrombosis	Thrombosis Canada	2021	View
ISTH Statement on Astrazeneca COVID-19 Vaccine and Thrombosis	ISTH	2021	View
THROMBOSIS CANADA UPDATED STATEMENT ON ASTRAZENECA VACCINE AND BLOOD CLOTS - Thrombosis Canada seeks to reassure the public regarding blood clot risk and COVID-19 vaccines	Thrombosis Canada	2021	View
Remdesivir for severe covid-19: a clinical practice guideline	BMJ Rapid Recommendation	2020	View
IFCC Information Guide on COVID-19	IFCC	2020	View
Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic: Interim Clinical Guidance from the Anticoagulant Forum	Anticoagulant Forum	2020	View
ISTH interim guidance on recognition and management of coagulopathy in COVID	ISTH	2020	View
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment	ISTH	2020	View
ISTH interim guidance to recognition and management of coagulopathy in COVID-19	ISTH	2020	View
Laboratory haemostasis monitoring in COVID-19	ISTH	2020	View
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19	Chinese Society on Thrombosis and Hemostasis	2020	View
Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic	Reviewed by UK ITP Forum	2020	View
Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19	ISTH SSC	2020	View
Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report	CHEST	2020	View
The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis	ISTH SSC	2020	View
COVID-19 and its implications for thrombosis and anticoagulation	ASH	2020	View
A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19	ISTH	2020	View
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays		2020	View
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline		2020	View
Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19 Related Illness	ISTH SSC	2020	View
Management of the thrombotic risk associated with COVID-19: Guidance for the hemostasis laboratory		2020	View
ISTH DIC subcommittee communication on anticoagulation in COVID-19	ISTH SSC	2020	View
Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19		2020	View
Venous Thromboembolism in COVID-19		2020	View
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality		2020	View
The hematology laboratory’s response to the COVID-19 pandemic: A scoping review		2020	View
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis		2020	View
Routine laboratory testing to determine if a patient has COVID-19	Cochrane COVID-19 Diagnostic Test Accuracy Group	2020	View

Other

Guideline Title	Organization	Year	Action
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis	ISTH SSC	2023	View
Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation	ISTH SSC	2023	View
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management		2023	View
Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care - Second update 2022	European Society of Anaesthesiology and Intensive Care	2023	View
Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation	ISTH SCC	2023	View
Management of rare inherited bleeding disorders: proposals of the French Reference Centre on Haemophilia and rare coagulation disorders	French Reference Centre on Haemophilia and rare coagulation disorders	2023	View
Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients		2023	View
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis	ISTH SSC	2022	View
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis	ISTH SSC	2022	View
Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH	ISTH SSC	2022	View
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)	ESC and endorsed by ESAIC	2022	View
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH	ISTH SSC	2022	View
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline	CHEST	2022	View
AGA Clinical Practice Update: Coagulation in Cirrhosis	AGA	2019	View
Perioperative Management of Direct Oral Anticoagulants in Cardiac Surgery: Practice Recommendations Based on Current Evidence		2022	View
Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH	ISTH SSC	2018/2019	View
Consensus document of the Spanish Society of Digestives Diseases and the Spanish Society of Thrombosis and Haemostasis on massive nonvariceal gastrointestinal bleeding and direct-acting oral anticoagulants	Spanish Society of Digestives Diseases and Spanish Society of Thrombosis and Haemostasis	2022	View
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia		2022	View
AANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’	ANMCO	2022	View
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes	ANMCO	2022	View
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	AHA / ASA	2022	View
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis	ISTH SSC	2022	View
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum	Anticoagulant Forum	2022	View
Managing invasive procedures in haemophilia patients with limited resources, extended half-life concentrates or non-replacement therapies in 2022		2022	View
Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding	AICE / SISET	2022	View
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute Cardio Vascular Care and the Asia-Pacific Heart Rhythm Society	ESC Working Group on Thrombosis	2022	View
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH	ISTH SSC	2022	View
Bleeding disorders in implant dentistry: a narrative review and a treatment guide		2022	View
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period	American College of Gastroenterology and Canadian Association of Gastroenterology	2022	View
Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document	Multidisciplinary Consensus	2022	View
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopenic purpura published by the International Society on Thrombosis and Haemostasis	European Renal Best Practice	2022	View
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)	German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)	2022	View
Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper	FCSA	2021	View
Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH	ISTH SSC	2021	View
European principles of care for women and girls with inherited bleeding disorders	European Association for Haemophilia and Allied Disorders	2021	View
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update		2021	View
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology	ISTH SSC	2021	View
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation	ISTH SSC	2021	View
2021 Guidelines on the Diagnosis and Management of VWD	ASH, ISTH, NHF, WFH	2021	View
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	European Heart Rhythm Association	2021	View
Comment: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation		2021	View
Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH	ISTH SSC	2020	View
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia	BSH	2020	View
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)	ECS	2020	View
Standardizing Care to Manage Bleeding Disorders in Adolescents with Heavy Menses—A Joint Project from the ISTH Pediatric/Neonatal and Women's Health SSCs	ISTH SSC	2020	View
WFH Guidelines for the Management of Hemophilia, 3rd edition	WFH	2020	View
Investigation and management of erythrocytosi		2020	View
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET	AICE	2020	View
ISTH Guidelines for Treatment of Thrombotic Thrombocytopenic Purpura	ISTH	2020	View
International Recommendations On The Diagnosis And Treatment Of Acquired Hemophilia A		2020	View
Anticoagulant therapy for splanchnic vein thrombosis	ISTH SSC	2020	View
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis	ISTH SSC	2020	View
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia		2020	View
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura	ISTH	2020	View
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism	ASH	2020	View
Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020	Canadian Stroke Best Practice Recommendations (CSBPR)	2020	View
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee	ACC	2020	View
EULAR recommendations for the management of antiphospholipid syndrome in adults	EULAR	2019	View
Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Edition	American Society for Apheresis	2019	View
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome	McMaster RARE-Bestpractices project group	2018	View
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when	European Myeloma Network	2018	View
Review of the NICE guidelines for multiple myeloma	NCBI	2017	View
Acquired hemophilia A: Updated review of evidence and treatment guidance.	HTRS	2017	View
Guideline for the diagnosis and management of the rare coagulation disorders. A United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology	UKHCDO / BCSH	2014	View
Patient self-testing and self-management oforal anticoagulant with vitamin K antagonists: guidance from the British Committee for Standards in Haematology	BCSH	2014	View
Diagnosis and management of acquired coagulation inhibitors: a guideline form UKHCDO	UKHCDO / BCSH	2013	View
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)	UKHCDO / BCSH	2013	View
WFH Guidelines for the Management of Hemophilia, 2nd edition	WFH	2012	View

Post-analytical

Guideline Title	Organization	Year	Action
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders	French Reference Centre on Haemophilia and Rare Coagulation Disorders	2023	View
WFH GUIDELINES for the MANAGEMENT of HEMOPHILIA – 3rd Edition	WFH	2020	View
A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH	ISTH SSC	2021	View
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer	ASH	2021	View
International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting	ICSH	2020	View
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory		2020	View
Guideline Papers	ICSH	2021	View
Recommendations on the Standardization of Critical Results in Hematology – Adult Population	ICSH	2016	View
Guideline Papers	BSH	2021	View

GUIDELINES